During the past decade, Regeneris Medical conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regeneris Medical" #1 sponsor was "Regeneris Medical" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored, "Neurolief Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regeneris Medical" #1 collaborator was "Global Alliance for Regenerative Medicine" with 3 trials as a collaborator, "Regeneris Medical" with 1 trials as a collaborator, "Regeneris Medical Inc" with 1 trials as a collaborator and "Robert W. Alexander, MD, FICS" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Regeneris Medical" are "Migraine" (2 trials), "Acute Migraine" (1 trials), "Alopecia Areata" (1 trials), "Altered Behavior in Alzheimer Disease" (1 trials) and "Back Pain" (1 trials). Many other conditions were trialed in "Regeneris Medical" in a lesser frequency.

Most popular intervention types in "Regeneris Medical" are "Drug" (5 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cellular Stromal Vascular Fraction" (1 trials), "Centricyte 1000" (1 trials), "Emulsification tSVF" (1 trials), "Fenofibrate" (1 trials) and "Intranasal Aptar Pharma Unit Dose System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regeneris Medical" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Regeneris Medical". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regeneris Medical, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regeneris Medical, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".